Tequin and Alendronate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tequin (gatifloxacin) and Alendronate sodium (alendronate sodium). Common drug interactions include spinal column stenosis among females and hypoglycaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Tequin and Alendronate sodium. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Tequin?

Tequin has active ingredients of gatifloxacin. eHealthMe is studying from 4,645 Tequin users. Check the latest studies of Tequin.

What is Alendronate sodium?

Alendronate sodium has active ingredients of alendronate sodium. It is often used in osteoporosis. eHealthMe is studying from 43,608 Alendronate sodium users. Check the latest studies of Alendronate sodium.



On Jul, 10, 2026

21 people who take Tequin and Alendronate sodium together, and have interactions are studied.

Tequin and Alendronate sodium drug interactions.

What are the common drug interactions of Tequin and Alendronate Sodium, by gender? *:

female:

  1. Spinal column stenosis (narrowing of spinal column)
  2. Cardiac failure congestive
  3. Joint effusion (presence of extra fluid in joint covering)
  4. Tendon disorder (disease of tendon)
  5. Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract)
  6. Spinal osteoarthritis (joint cartilage loss in spine)
  7. Bone marrow failure
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Plasmacytosis (presence of lots of plasma cells in bone or other tissues)
  10. Nail dystrophy (bed formation of nail)

male:

  1. Hypoglycaemia (deficiency of glucose in the bloodstream)
  2. Abasia (inability to walk)
  3. Bronchial obstruction (blockage of the breathing passages to the lungs)
  4. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  5. Cerebral atrophy (decrement in size of brain)
  6. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Cough
  9. Decreased appetite
  10. Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)

What are the common drug interactions of Tequin and Alendronate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Fall
  2. Anxiety
  3. Dysphonia (speech disorder attributable to a disorder of phonation)
  4. Facial pain
  5. Groin pain
  6. Injury
  7. Intervertebral disc disorder (spinal disc disorder)
  8. Leukopenia (less number of white blood cells in blood)
  9. Lumbar vertebral fracture
  10. Multiple myeloma (cancer of the plasma cells)

What are the existing conditions these people have? *

  1. Pain: 14 people, 66.67%
  2. Muscle Spasms (muscle contraction): 14 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tequin and Alendronate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tequin and Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tequin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Alendronate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tequin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alendronate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gatifloxacin and alendronate sodium (the active ingredients of Tequin and Alendronate sodium, respectively), and Tequin and Alendronate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: